Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
ICT-01 by ImCheck Therapeutics for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia): Likelihood of Approval
ICT-01 is under clinical development by ImCheck Therapeutics and currently in Phase II for Acute Myelocytic Leukemia (AML, Acute Myeloblastic...
Data Insights
ICT-01 by ImCheck Therapeutics for Non-Small Cell Lung Cancer: Likelihood of Approval
ICT-01 is under clinical development by ImCheck Therapeutics and currently in Phase II for Non-Small Cell Lung Cancer. According to...